{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:19:39Z","timestamp":1790803179103,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014013","name":"UKRI","doi-asserted-by":"publisher","award":["EP\/V051490\/1"],"award-info":[{"award-number":["EP\/V051490\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ccm.2022.11.013","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T02:12:14Z","timestamp":1669083134000},"page":"385-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["COVID-19 in Patients with Chronic Lung Disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Jessica Fae","family":"Calver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Gisli","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-2600(20)30167-3","article-title":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?","volume":"8","author":"Halpin","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.11.013_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"7821","key":"10.1016\/j.ccm.2022.11.013_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib4","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41467-021-24467-0","article-title":"Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity","volume":"12","author":"Bui","year":"2021","journal-title":"Nat Commun"},{"issue":"7798","key":"10.1016\/j.ccm.2022.11.013_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib6","doi-asserted-by":"crossref","first-page":"2001123","DOI":"10.1183\/13993003.01123-2020","article-title":"Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue","volume":"56","author":"Aguiar","year":"2020","journal-title":"Eur Respir J"},{"issue":"6518","key":"10.1016\/j.ccm.2022.11.013_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ccm.2022.11.013_bib8","doi-asserted-by":"crossref","first-page":"100759","DOI":"10.1016\/j.jbc.2021.100759","article-title":"The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection","volume":"296","author":"Carlos","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry Depends on ACE2 and TMPRSS2 and is Blocked by a clinically Proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib10","first-page":"554","article-title":"COVID-19 spike-host cell receptor GRP78 binding site prediction","volume":"80","author":"Ibrahim","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-022-00930-2","article-title":"Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduction Targeted Ther"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40733-021-00075-z","article-title":"Asthma and COVID-19: a dangerous liaison?","volume":"7","author":"Lombardi","year":"2021","journal-title":"Asthma Res Pract"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2","volume":"146","author":"Jackson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaci.2020.05.004","article-title":"Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells","volume":"146","author":"Kimura","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib18","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41467-020-18781-2","article-title":"Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium","volume":"11","author":"Sajuthi","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ccm.2022.11.013_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/all.12627","article-title":"Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells","volume":"70","author":"Contoli","year":"2015","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.ccm.2022.11.013_bib20","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.4049\/jimmunol.0901194","article-title":"Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells","volume":"184","author":"Gill","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jaci.2020.05.029","article-title":"Molecular pharmacology of ciclesonide against SARS-CoV-2","volume":"146","author":"Kimura","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib22","doi-asserted-by":"crossref","first-page":"e01648","DOI":"10.1128\/JVI.01648-20","article-title":"The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells","volume":"95","author":"Matsuyama","year":"2020","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamainternmed.2021.6759","article-title":"Efficacy of inhaled ciclesonide for outpatient treatment of adolescents and adults with symptomatic COVID-19: a randomized clinical trial","volume":"182","author":"Clemency","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib24","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jaci.2021.03.011","article-title":"Asthma and viruses: a focus on rhinoviruses and SARS-CoV-2","volume":"147","author":"Padayachee","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaip.2020.12.045","article-title":"Eosinophilia in asthma patients is protective against severe COVID-19 illness","volume":"9","author":"Ferastraoaru","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/all.14516","article-title":"COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey","volume":"76","author":"Matucci","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2020.05.051","article-title":"Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype","volume":"146","author":"Camiolo","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-020-01605-8","article-title":"Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma","volume":"22","author":"Kermani","year":"2021","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib29","doi-asserted-by":"crossref","first-page":"2002226","DOI":"10.1183\/13993003.02226-2020","article-title":"Effect of asthma and asthma medication on the prognosis of patients with COVID-19","volume":"57","author":"Choi","year":"2021","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib30","doi-asserted-by":"crossref","first-page":"2003142","DOI":"10.1183\/13993003.03142-2020","article-title":"The impact of COVID-19 on patients with asthma","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib31","doi-asserted-by":"crossref","first-page":"2101209","DOI":"10.1183\/13993003.01209-2021","article-title":"Asthma and COVID-19 risk: a systematic review and meta-analysis","volume":"59","author":"Sunjaya","year":"2022","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ccm.2022.11.013_bib32","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jaip.2020.05.006","article-title":"Asthma prolongs intubation in COVID-19","volume":"8","author":"Mahdavinia","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ccm.2022.11.013_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijid.2021.09.026","article-title":"COVID vaccination and asthma exacerbation: might there be a link?","volume":"112","author":"Colaneri","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5603\/ARM.a2021.0015","article-title":"GOLD 2021 guidelines for COPD- what's new and why","volume":"89","author":"Gupta","year":"2021","journal-title":"Adv Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccm.2013.11.001","article-title":"Acute COPD exacerbations","volume":"35","author":"Wedzicha","year":"2014","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2022.11.013_bib37","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.eclinm.2021.100789","article-title":"COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis","volume":"33","author":"Gerayeli","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib38","doi-asserted-by":"crossref","first-page":"19251","DOI":"10.1038\/s41598-021-98749-4","article-title":"Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients","volume":"11","author":"Lacedonia","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ccm.2022.11.013_bib39","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ntr\/ntaa082","article-title":"Smoking is associated with COVID-19 progression: a meta-analysis","volume":"22","author":"Patanavanich","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"10","key":"10.1016\/j.ccm.2022.11.013_bib40","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/jmv.25889","article-title":"The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis","volume":"92","author":"Zhao","year":"2020","journal-title":"J\u00a0Med Virol"},{"issue":"6","key":"10.1016\/j.ccm.2022.11.013_bib41","doi-asserted-by":"crossref","first-page":"e0217803","DOI":"10.1371\/journal.pone.0217803","article-title":"Deficient pulmonary IFN-beta expression in COPD patients","volume":"14","author":"Garcia-Valero","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/medicina58010121","article-title":"Deciphering respiratory-virus-associated interferon signaling in COPD airway epithelium","volume":"58","author":"Guo-Parke","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib43","doi-asserted-by":"crossref","first-page":"1700739","DOI":"10.1183\/13993003.00739-2017","article-title":"Toll-like receptors in COPD","volume":"49","author":"Hansbro","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib44","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is Detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cjp2.224","article-title":"Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD","volume":"7","author":"Fliesser","year":"2021","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.ccm.2022.11.013_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2020.05.013","article-title":"Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD","volume":"18","author":"Saheb Sharif-Askari","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.ccm.2022.11.013_bib47","doi-asserted-by":"crossref","first-page":"584637","DOI":"10.3389\/fphar.2020.584637","article-title":"Age-dependent assessment of genes involved in cellular senescence, telomere, and mitochondrial pathways in human lung tissue of smokers, COPD, and IPF: associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-furin-DPP4 Axis","volume":"11","author":"Maremanda","year":"2020","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.ccm.2022.11.013_bib48","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/all.14429","article-title":"Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors","volume":"75","author":"Radzikowska","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.ccm.2022.11.013_bib49","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00455.2020","article-title":"Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19","volume":"320","author":"Aloufi","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ccm.2022.11.013_bib50","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2147\/COPD.S265004","article-title":"Clinical courses and outcomes of patients with chronic obstructive pulmonary disease during the COVID-19 epidemic in Hubei, China","volume":"15","author":"Hu","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ccm.2022.11.013_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cophys.2021.03.005","article-title":"Pulmonary function and COVID-19","volume":"21","author":"Thomas","year":"2021","journal-title":"Curr Opin Physiol"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib52","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2020.09.034","article-title":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon","volume":"147","author":"Finney","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2022.11.013_bib53","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib54","doi-asserted-by":"crossref","first-page":"2001009","DOI":"10.1183\/13993003.01009-2020","article-title":"Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective","volume":"55","author":"Halpin","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2022.11.013_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.11.013_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.11.013_bib57","doi-asserted-by":"crossref","first-page":"e0255659","DOI":"10.1371\/journal.pone.0255659","article-title":"Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis","volume":"16","author":"Alqahtani","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2022.11.013_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/1753466621995043","article-title":"Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study","volume":"15","author":"Choi","year":"2021","journal-title":"Ther Adv Respir Dis"},{"issue":"7","key":"10.1016\/j.ccm.2022.11.013_bib59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.202105-1137LE","article-title":"The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study","volume":"204","author":"Crichton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0092-8674(00)80570-X","article-title":"Cystic fibrosis and the salt controversy","volume":"96","author":"Guggino","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00146807","article-title":"Inhibition of airway proteases in cystic fibrosis lung disease","volume":"32","author":"Griese","year":"2008","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2022.11.013_bib62","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI2865","article-title":"Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells","volume":"101","author":"DiMango","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.ccm.2022.11.013_bib63","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1172\/JCI119828","article-title":"Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa","volume":"100","author":"Heeckeren","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.ccm.2022.11.013_bib64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.20452\/pamw.15630","article-title":"Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes","volume":"130","author":"Marcinkiewicz","year":"2020","journal-title":"Pol Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib65","doi-asserted-by":"crossref","first-page":"L408","DOI":"10.1152\/ajplung.00225.2020","article-title":"SARS-CoV-2 (COVID-19) and cystic fibrosis","volume":"319","author":"Stanton","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"10.1016\/j.ccm.2022.11.013_bib66","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1172\/JCI31499","article-title":"Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity","volume":"117","author":"Ornatowski","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.ccm.2022.11.013_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","article-title":"COVID-19 meets Cystic Fibrosis: for better or worse?","volume":"21","author":"Peckham","year":"2020","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib68","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.jcf.2022.04.004","article-title":"Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis","volume":"21","author":"Michos","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2022.11.013_bib70","first-page":"e2020009","article-title":"Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire","volume":"37","author":"Baughman","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib71","first-page":"657","article-title":"A\u00a0review of the presentation and outcome of sarcoidosis in coronavirus disease 2019","volume":"7","author":"George","year":"2021","journal-title":"J\u00a0Clin Transl Res"},{"issue":"5","key":"10.1016\/j.ccm.2022.11.013_bib72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MCP.0000000000000812","article-title":"COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes","volume":"27","author":"Kahlmann","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2022.11.013_bib73","doi-asserted-by":"crossref","first-page":"2004125","DOI":"10.1183\/13993003.04125-2020","article-title":"Interstitial lung disease increases susceptibility to and severity of COVID-19","volume":"58","author":"Lee","year":"2021","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib74","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"A\u00a0mechanism for regulating pulmonary inflammation and fibrosis: the integrin \u03b1v\u03b26 binds and activates latent TGF \u03b21","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ccm.2022.11.013_bib75","doi-asserted-by":"crossref","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","article-title":"A\u00a0potential role for integrins in host cell entry by SARS-CoV-2","volume":"177","author":"Sigrist","year":"2020","journal-title":"Antivir Res"},{"issue":"6","key":"10.1016\/j.ccm.2022.11.013_bib76","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI27183","article-title":"Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury","volume":"116","author":"Jenkins","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.ccm.2022.11.013_bib77","doi-asserted-by":"crossref","first-page":"e1005804","DOI":"10.1371\/journal.ppat.1005804","article-title":"An epithelial integrin regulates the amplitude of protective lung interferon responses against multiple respiratory pathogens","volume":"12","author":"Meliopoulos","year":"2016","journal-title":"Plos Pathog"},{"issue":"4","key":"10.1016\/j.ccm.2022.11.013_bib78","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2353\/ajpath.2009.080160","article-title":"Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q)","volume":"174","author":"Xu","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ccm.2022.11.013_bib79","doi-asserted-by":"crossref","first-page":"668024","DOI":"10.3389\/fmed.2021.668024","article-title":"The MUC5B promoter Polymorphism associates with severe COVID-19 in the European population","volume":"8","author":"van Moorsel","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.ccm.2022.11.013_bib80","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of Hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study","volume":"202","author":"Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.ccm.2022.11.013_bib82","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2022.11.013_bib83","doi-asserted-by":"crossref","first-page":"102744","DOI":"10.1016\/j.jaut.2021.102744","article-title":"Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups","volume":"125","author":"Ferri","year":"2021","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib84","doi-asserted-by":"crossref","first-page":"00082","DOI":"10.1183\/23120541.00082-2022","article-title":"Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis","volume":"8","author":"Karampitsakos","year":"2022","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/rccm.202112-2765LE","article-title":"COVID-19 vaccine in patients with exacerbation of idiopathic pulmonary fibrosis","volume":"206","author":"Sgalla","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2022.11.013_bib86","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1164\/rccm.202205-0902LE","article-title":"COVID-19 mRNA vaccines and ILD exacerbation: causation or just a temporal association?","volume":"206","author":"Ehteshami-Afshar","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.11.013_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020922799","article-title":"Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?","volume":"10","author":"Horn","year":"2020","journal-title":"Pulm Circ"},{"issue":"12","key":"10.1016\/j.ccm.2022.11.013_bib88","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1513\/AnnalsATS.202005-521OC","article-title":"A\u00a0survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the Process of care","volume":"17","author":"Lee","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.ccm.2022.11.013_bib89","doi-asserted-by":"crossref","first-page":"1702638","DOI":"10.1183\/13993003.02638-2017","article-title":"A\u00a0potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib90","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"10.1016\/j.ccm.2022.11.013_bib91","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1513\/AnnalsATS.202008-1014ED","article-title":"COVID-19 and pulmonary arterial hypertension: early data and many questions","volume":"17","author":"Farha","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.ccm.2022.11.013_bib92","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020933480","article-title":"Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection","volume":"10","author":"Sahay","year":"2020","journal-title":"Pulm Circ"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523122001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523122001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:17:34Z","timestamp":1759454254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523122001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0272523122001290"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2022.11.013","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in Patients with Chronic Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2022.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}